Cargando…
Non‐vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta‐analysis
BACKGROUND: Current guidelines recommend oral anticoagulation (OAC) following transcatheter aortic valve replacement (TAVR) in patients with clinical indication, but the optimal antithrombotic regimen remains uncertain. We aimed to compare the efficacy and safety of non‐vitamin K oral anticoagulants...
Autores principales: | Chen, Yi‐feng, Liu, Fei, Li, Xi‐wen, Zhang, Hou‐jing, Liu, Yi‐ge, Lin, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019885/ https://www.ncbi.nlm.nih.gov/pubmed/35191074 http://dx.doi.org/10.1002/clc.23793 |
Ejemplares similares
-
Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022) -
Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in
Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve
Replacement: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023) -
Non-Vitamin K Oral Anticoagulant After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
por: Li, Dongxu, et al.
Publicado: (2022) -
Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021) -
Efficacy and safety of antithrombotic therapy with non-vitamin K
antagonist oral anticoagulants after transcatheter aortic valve replacement: a
systematic review and meta-analysis
por: An, Qing, et al.
Publicado: (2021)